HOME >> BIOLOGY >> NEWS
Immerge BioTherapeutics announces new findings addressing key safety risk in xenotransplantation

Charlestown, MA, July 14, 2003 -- In this issue of the journal Virology, (Vol. 312, Number 2, August 1, 2003) researchers from Immerge BioTherapeutics, Inc., (a BioTransplant Incorporated (Nasdaq:BTRN) /Novartis Pharma AG (NYSE:NYS) joint venture company) announced that recombination between porcine and human endogenous retrovirus was not detected when using sensitive laboratory tests, leading the authors to conclude that the creation of a new virus from the two was highly unlikely. Although the risk of recombination is purely theoretical, it has been of concern to xenotransplant researchers. This study represents an important finding and the most recent advance in the Immerge safety program, which is dedicated to addressing potential issues in the safety risk of pig-to-human xenotransplantation.

"We utilized a laboratory model to simulate PERV (porcine endogenous retrovirus) transmission by infecting human cells with the virus," said Dr Clive Patience, Director of the Safety Program at Immerge. "We found that human retrovirus elements were not detectable in the PERV particles released from the infected human cells. These results are encouraging, as we used very sensitive assays that can detect 1 out of 50,000 to 1 out of 10 million elements. Therefore, if human cells were ever to become infected by PERV, the likelihood of porcine and human viruses recombining to form a novel infectious virus is extremely remote."

PERV is a natural virus in pigs, but does not cause any disease in these animals. In certain laboratory conditions PERV can infect cells from other species, including some human cells. However, there are no indications that PERV infection has occurred in living individuals, including humans that have been treated with pig tissues or those that are in regular direct contact with living pig cells or tissues.

"The risk of cross-species spread of PERV should be balanced by the potential efficacy of the transplanted tissue," comme
'"/>

Contact: Susan Hayes
shayesconsult@earthlink.net
212-533-4472
S. Hayes Consulting
14-Jul-2003


Page: 1 2

Related biology news :

1. Immerge reports PERVs most infectious to human cells not part of germ-line DNA of mini-swine
2. Immerge BioTherapeutics announces identification of PERV receptor
3. Immerge biotherapeutics identifies miniature swine that do not transmit pig retrovirus to humans
4. Secretary of Energy announces seven E.O. Lawrence Award Winners
5. Popular Science announces Third Annual Brilliant 10
6. The American Phytopathological Society announces 2004 awards
7. NSF announces six FIBR awards to tackle some of biologys most challenging questions
8. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
9. JGI announces community sequencing program portfolio
10. APS announces the winners of its 2004 postdoctoral fellowship in physiological genomics
11. National Corn Growers Association announces valuable maize genome data now available to scientists

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/7/2020)... ... January 06, 2020 , ... Myant Inc. , the pioneers in Textile ... bring to life its vision of a world where textile-based interfaces knitted into everyday ... digital sphere, and the physical IoT-enabled environment. The experience at Myant’s booth will challenge ...
(Date:12/23/2019)... ... December 23, 2019 , ... Detecting a small amount of ... reverse situation can be quite daunting. Over the years, several methodologies have been ... and announces advances of their own and also that of one of their ...
(Date:12/18/2019)... ... 2019 , ... Intelligent.com, a trusted resource for online degree ... Degree Programs for 2020. The comprehensive research guide is based on an assessment ... based on curriculum quality, graduation rate, reputation, and post-graduate employment. , The ...
Breaking Biology News(10 mins):
(Date:12/27/2019)... ... December 27, 2019 , ... Leak Detection Associates (LDA), the ... Biotechnology, Medical Device and Food Packaging Industries is excited to celebrate the completion ... CLJ Holdings in February, 2019, a comprehensive and aggressive reorganization plan was implemented ...
(Date:12/18/2019)... (PRWEB) , ... December 17, 2019 , ... ... received its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since the company’s ... competitors, Stryker Sustainability Solutions and SterilMed (a Johnson & Johnson company) have received ...
(Date:12/14/2019)... ... December 12, 2019 , ... Leak ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is ... LT80 (LOW TEMPERATURE -80C) helium leak testing system is designed for testing containers ...
(Date:12/4/2019)... REDCAR, United Kingdom (PRWEB) , ... December 03, ... ... provider of recombinant antibody products and services, today announced a partnership with the ... of Chicago, University of Toronto, and UC San Francisco (UCSF) with a common ...
Breaking Biology Technology:
Cached News: